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Lipid-laden alveolar macrophages and pH monitoring have been used in the diagnosis of chronic aspiration in children with
gastroesophageal reﬂux (GER). This study was conducted to prove a correlation between the detection of alimentary pulmonary
fat phagocytosis and an increasing amount of proximal gastroesophageal reﬂux. It was assumed that proximal gastroesophageal
reﬂux better correlates with aspiration than distal GER. Patients from 6 months to 16 years with unexplained recurrent wheezy
bronchitis and bronchial hyperreactivity, or recurrent pneumonia with chronic cough underwent 24-hour double-channel pH
monitoring and bronchoscopy with bronchoalveolar lavage (BAL). Aspiration of gastric content was determined by counting
lipid laden alveolar macrophages from BAL specimens. There were no correlations between any pH-monitoring parameters
and counts of lipid-laden macrophages in the whole study population, even when restricting analysis to those with abnormal
reﬂux index expressing clinically signiﬁcant GER. Quantifying lipid-laden alveolar macrophages from BAL in children with
gastroesophageal-related respiratory disorders does not have an acceptable speciﬁcity to prove chronic aspiration as an underlying
etiology. Therefore, research for other markers of pulmonary aspiration is needed.
1.Introduction
Gastroesophageal reﬂux is associated with a variety of respi-
ratory symptoms from infancy and childhood [1] to adults
[2], and may manifest by respiratory symptoms alone [3, 4].
In a birth cohort study, the association of heartburn and
acid regurgitation to asthma symptoms increased with age
[5]. Thus, looking for symptoms of GER solely in children
with unexplained respiratory disorders may underdiagnose
GER-related disease. Children and adults may not only
present asthma symptoms, but also recurrent pneumonia,
chronic cough, and signs of upper airway involvement [6, 7].
Thus, aspiration of gastric content into the airways may play
a relevant role. This phenomenon is called microaspiration
[8] and evidence supports this event as the most common
etiology of laryngopulmonary symptoms [9].
ThereforepHmonitoringoftheesophagusanddetection
of lipids in alveolar macrophages may be useful in the
diagnosis of chronic aspiration from gastroesophageal reﬂux
in children with otherwise unexplained chronic lung disease.
Accumulation of lipids by phagocytosis of alveolar ma-
crophages is considered to be suggestive for chronic aspira-
tion [10, 11].
The knowledge of using lipid-laden alveolar macrophage
(LLAMs)indiagnosingchronicaspirationcamefromanimal
studies: Colombo and coworkers followed rabbits with
experimental aspiration of milk [12]. They found a short-
time increase of LLAMs after a single instillation of milk into
the trachea whereas daily repeated instillation of milk for ﬁve
days lead to detection of LLAMs for the two following weeks.
In a control group with saline instillation, no LLAMs could
be found.
A number of further studies looked for LLAMs in BAL
of patients suspicious for GER-related chronic lung disease,
but studies comparing BAL results with pH monitoring of
the esophagus are rare, sample sizes are small, and results
contrary [13–15].
The hypothesis of our present study was that reﬂux
episodes into the proximal esophagus should correlate with
aspiration of gastric content, that is, the more reﬂux into the2 Pulmonary Medicine
proximal esophagus, the more phagocytosis of reﬂux content
inbronchoalveolarmacrophages.Therefore,countingLLAM
in BAL of children with chronic lung disease would correlate
with pH-monitoring parameters in the esophagus.
2. Methods
2.1. Study Population. Our retrospective study surveys 448
six-month to 16-year-old children (median 4.12 years, range
0.6–16 years). The study was performed over a time period
of three years from 1999–2002. Children were referred for
evaluation of recurrent wheezing bronchitis and recurrent
pneumonia, related to chronic cough. Symptoms had to per-
sist for at least one year. Exclusion criteria for participation
were cystic ﬁbrosis, immunodeﬁciency, severe neurological
disease, and relevant aeroallergic sensitizations, chronic for-
eign body aspiration, and pulmonary malformations. When
appropriate tests were performed, bronchoscopy and pH-
monitoring were performed as elective routine clinical work
up in a disease-free period: patients underwent diagnostic
bronchoscopy in general anesthesia. Bronchoalveolar lavage
was performed in the right middle lobe or the lobe most
aﬀected by the underlying disease. Three times 1ml/kg
body weight of 0.9%, body warmed, saline solution was
instilled and gently suctioned. Lavage ﬂuid was centrifuged
with 1000rpm for 10min with a cytospin 2000 (Shandon,
Southern Products, UK). Oil-Red-O-stained slides were
examined microscopically for lipid phagocytosis into alveo-
lar macrophages, consequently called “lipid-Laden alveolar
macrophages” (LLAMs).
In a pilot study, we compared counting LLAMs and
expressing them as a ratio of the total amount of alveolar
macrophages (AMs) and compared this ratio to the scoring
LLAM-index method of Colombo [16]. Brieﬂy with this
method a total of 300 alveolar macrophages were screened
for cytoplasmatic lipid granules, and AMs were graded to
their content of lipid stained: 0 = cytoplasm not opaciﬁed,
1 = up to 1/4 opaciﬁed, 2 = up to 1/2 opaciﬁed, 3 = up
to 3/4 opaciﬁed, and 4 = totally opaciﬁed cytoplasm. Thus,
LLAM scores may range from 0 to 1200. Counting LLAMs
may result in ratios of 0–100% of 300AMs. Researchers
who scored the LLAMs were blinded to the pH-monitoring
results. Our pilot study had shown a good correlation
between the ratio of LLAM/AM and the Colombo method of
qualitative scoring LLAM (Pearson’s r = 0.9890). For details
see Figure 1. Thus, we could use this ratio of LLAM/AM
count for further evaluation in the study.
2.2. Monitoring of pH. In a timely manner to the broncho-
scopy, patients underwent double-channel 24hr esophageal
pH monitoring according to the ESPGHAN standardized
protocol [17]. None of the subjects had received antireﬂux
treatment before. A monocrystalline antimony double-
channel pH probe (Medtronic Synectics Medical, Sweden)
was calibrated in buﬀers of pH 7.01 and 1.07 and then placed
transnasally into the esophagus. The distance of the two pH
sensors on the probe was adjusted according to the patient’s
body height, using our previously published formula [18].
The upper probe position of the sensors was always chosen
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Figure 1: Pearson’s correlation of LLAM scoring with LLAMs
(&AMs). High correlation of the percentage of fat containing AMs
(LLAMs/%AMs) (from a total of 300screened AMs) and their fat
content described by the LLAMs score.
to be set at the line between the clavicles. The lower probe
position was set in the distal esophagus.
Therefore, we used three diﬀerent distances between the
sensors: 5cm in patients with a body height of ≤80cm,
10cm in patients with a body height of ≤120cm, and
15cm in patients with a body height of >120cm. This
facilitates interindividual comparability for esophageal pH-
monitoring. After adjusting the probe for an optimal posi-
tion within the esophagus using a chest X-ray, probes were
connected to a portable digital recorder (Digitrapper MK III,
Synectics Medical AB, Sweden). Patients and their guardians
were then asked to keep a diary for the next 24hours. This
diary included data on the time and kind of consumed
meals,beverages,anddrugsaswellasposture.After24hours,
data were analyzed by the software “Esophogram” (Synectics
Medical AB, Sweden). Reﬂux episodes were deﬁned as a
decrease of esophageal ph below 4 for longer than ﬁve
seconds, followed by an increase of pH for a minimum of
4.5, thus avoiding oscillating phenomena. This enabled us to
detect the number of reﬂux episodes at each sensor in the
past 24hours, the longest reﬂux episode, and the number of
long-lasting reﬂux episodes (>5minutes). The summarized
time of all reﬂux episodes divided by the total recording time
(in general over a period of 24hours) is also known as the
“reﬂux index.”
2.3. Statistical Analysis. Mean values were given as medi-
ans ± ranges. Linear regression analysis (Pearson’s correla-
tion coeﬃcient) was used to assess the correlation between
pH-monitoring parameters and percentage of lipid-laden
alveolar macrophages (LLAMs). A probability value of P<
0.05indicatedstatisticalsigniﬁcancebetweengroups.Testing
was performed using SPSS 11.0 for windows (SPSS Inc.,
Chicago, Illinois USA).
3. Results
Percentages of lipid-laden alveolar macrophages in BAL
(LLAM/AM) were correlated to esophageal pH-monitoringPulmonary Medicine 3
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Figure 2: Scatter plots of parameters from the proximal channel of a double-channel 24hr pH probe in the esophagus versus LLAM count
(in % of 300AMs; n = 448). (a) Total number of reﬂux episodes: no correlation with the percentage of fat containing AMs (LLAMs/%AMs)
in the regression analysis (r =− 0.042). (b) Number of reﬂux episodes, lasting longer than ﬁve minutes: no correlation with the percentage
of fat containing AM (LLAMs/%AMs) in the regression analysis (r =− 0.017). (c) Duration (minutes) of the longest reﬂux episode: no
correlation with the percentage of fat containing AMs (LLAMs/%AMs) in the regression analysis (r =− 0.022). (d) Reﬂux Index (percentage
of time pH below 4): no correlation with the percentage of fat containing AMs (LLAMs/%AMs) in the regression analysis (r =− 0.009).
parameters. No correlations could be revealed between the
ratioofLLAM/AMandresultsofpH-monitoringparameters
at the proximal channel of the pH-probe linear regression
analysis (Pearson’s correlation coeﬃcient) of the number of
reﬂux episodes (r =− 0.042), the number of reﬂux episodes
lastinglongerthan5minutes(r =− 0.017),thelongestreﬂux
episode (r =− 0.022) and at last the reﬂux index (r =
−0.009) did not show a signiﬁcant correlation to LLAMs as
the proposed marker of aspiration (see Figures 2(a), 2(b),
2(c),a n d2(d)). This was also true when correlating pH
valuesfromthedistalchanneltotheratioofLLAM/AM(data
not shown).
Further investigation was restricted to patients with
presumedGER,indicatedbypositivepH-monitoringresults.
Their reﬂux index needed to be ≥5% at the distal channel
(n = 164). In these patients, mean ratio of LLAM/AM was
5.04%whereasmeanratioofLLAM/AMintheotherpatients
without GER (RI < 5%) at the distal channel was 4.3%. The
results missed statistical signiﬁcance (see Table 1).
Again, there were no correlations between results of pH-
monitoring parameters (e.g., number of reﬂux episodes,
reﬂux episodes lasting longer than ﬁve minutes, the longest
Table 1: Regression analysis from pH-monitoring parameters
correlated with LLAMs (% AMs) from BAL with patients stratiﬁed
forRI>5%orRI<5%atdistalchannelrecordings.Nocorrelations
could be found in these subgroups. P values indicate no statistical
diﬀerences for these correlations in patients with RI < 5% at distal
channel recordings (n.s. = not signiﬁcant).
No. of
reﬂux
episodes
No. of reﬂux
episodes >5
min.
Longest
reﬂux
episode
Reﬂux index
Ratio (%)
LLAM/AM r = 0.228 r =− 0.0264 r =− 0.11 r =− 0.0387
n.s. n.s. n.s. n.s.
reﬂux episode, and reﬂux index) and the ratio of LLAM/AM
counts in both subgroups (data not shown).
DespitemorereﬂuxactivityinthepH-monitoringresults
inchildrenyoungerthanfouryearsofage,wedidnotdetecta
correlation of age to parameters of pH monitoring and ratio
of LLAM/AM than in patients four to 16years of age (data
not shown).4 Pulmonary Medicine
4. Discussion
Our study was done to examine the predictive value of
pathological ﬁndings from pH monitoring and the detection
of LLAMs as to chronic aspiration in gastroesophageal
reﬂux. We hypothesized that an increasing amount of
reﬂuxes detected at the proximal tube of the pH mon-
itoring was indicative for pulmonary aspiration detected
by LLAMs. The weak correlation between values from
pH monitoring and the LLAM scores proved the null
hypotheses. Nonetheless, the results from our study have to
be interpreted with the restriction that lipids incorporated
by alveolar macrophages are not exclusively observed in
pulmonary aspiration. Fat in macrophages can also be
of endogenous origin as suggested by studies on acute
pneumonia [19] and in fat infusions [20]. Therefore, in
gastroesophageal reﬂux, lipid-laden alveolar macrophages
do not deﬁnitely discriminate aspirators from nonaspi-
rators. Another possible confounder is the half-life of
lipids in alveolar macrophages, which is only known from
animal models [12]. In patients with pathological pH-
measurements, aspiration might have taken place before
pH-probe measurements were performed, resulting in false-
negative results.
We nevertheless believe that LLAMs have their role in
the diﬀerential diagnosis of pulmonary aspiration. Even
the absence of a correlation does not ban LLAMs as a
diagnostictool.Viceversa,pHmonitoringmightnotprovide
relevant results as to the underlying pathology of GER. As
we know from impedance measurements of the esophageal
motility, also alkaline reﬂuxes or an insuﬃciency of the
upper esophageal sphincter might be responsible for the
aspiration. Here, proximal reﬂuxes will only contribute
to the risk of aspiration, and with a suﬃcient upper
sphincter function, reﬂux episodes will not result in aspira-
tion.
Over all, the speciﬁcity and sensitivity for the detection
of lipids in alveolar macrophages appears not high enough
for its sole use as a clinical decision tool. Additional
markers of aspiration (e.g., pepsin, radioactive tracers such
as Technetium-99m, or food additives might better provide
evidence for recurrent aspiration and its role in chronic lung
disease [9, 21, 22]).
5. Conclusion
This study has shown that counting or scoring of lipid-laden
alveolar macrophages from bronchoalveolar lavage is not a
reliable tool to solely test for chronic aspiration diagnosed by
esophageal pH monitoring in children with predominantly
asymptomatic gastroesophageal reﬂux. Other markers of
aspiration are needed for clinical practice to prove the causal
relationship between gastroesophageal reﬂux and chronic
aspiration. These markers should be of exogenous origin
to enhance speciﬁcity of the test by avoiding endogenous
interferences. Other tools to better detect GER (apart from
esophageal pH monitoring) should be introduced to cover
also non acid reﬂux (e.g., multilocal impedance measure-
ments of the esophagus).
Abbreviations
AM: Alveolar macrophage
LLAM: Lipid-laden alveolar macrophage
GER(D): Gastroesophageal reﬂux (disease)
BAL: Bronchoalveolar lavage
RI: Reﬂux index.
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